PDE4B and interstitial lung disease: This study aimed to evaluate the therapeutic potential of Nerandomilast (a PDE4B inhibitor) in an experimental IIM-ILD model and to investigate its underlying mechanisms.<h4>Methods</h4>An IIM-ILD mouse model was established by immunization with skeletal muscle homogenate.